市場調查報告書
商品編碼
1433345
全球關節重建設備市場 2023-2030Global Joint Reconstruction Devices Market 2023-2030 |
在預測期內(2023-2030年),全球關節重建器材市場預計將以 4.3% 的CAGR成長。市場成長的重要因素包括人口老化、骨關節炎盛行率增加、微創技術以及大型關節重建手術數量的增加。隨著關節炎、骨質疏鬆、膝關節損傷等骨科疾病的日益流行,導致骨骼損傷且病情嚴重,關節重建手術是最終的治療方法。 2021 年 12 月,英國與工作相關的肌肉骨骼疾病統計報告稱,2020/21 年有 47 萬名工人患有與工作相關的肌肉骨骼疾病(新發或長期存在)。每 10 萬名工人中有 1,420 人患有此病,佔所有工作引起的健康不良的 28.0%。
全球關節重建器械市場根據技術和關節類型進行區隔。根據技術,市場區隔為關節置換、截骨術、關節鏡檢查、表面置換術和關節固定術。此外,根據關節類型,市場可區隔為膝關節、髖關節、肩關節、踝關節等。其中,其他還包括樞軸關節、鞍座關節。在這些技術中,截骨術由於功能改善、疼痛減輕、惡化緩慢,預計將佔據相當大的市場佔有率。
在關節中,膝關節區隔市場預計將在預測期內成長。此區隔市場是由全球骨質疏鬆症和關節炎日益普及所推動的。根據美國國立衛生研究院的數據,在美國,骨質疏鬆症的盛行率很高,50歲以上人口中有12.6%患有骨質疏鬆症。此外,每年有 150 萬人遭受骨折的折磨,這增加了對膝關節置換產品的需求。治療骨質疏鬆症和關節炎所需的替代療法的微創手術技術的進步預計將推動對產品的需求。此外,膝骨關節炎在老年族群中廣泛流行。膝關節重建是一種有效的治療方法,有助於減輕疼痛並改善各年齡層患者的功能和生活方式,尤其是老年族群。 60歲及以上人口在人口中的數量和比例不斷增加。根據世界衛生組織的數據,2019年,60歲以上的人口數為10億人。到 2030 年,這一數字將增至 14 億,到 2050 年將增至 21 億。這種成長正在以前所未有的速度發生,並將在未來幾十年加速,特別是在發展中國家。許多國家不斷擴大的老年人口基數需要關節置換和重建手術來改善他們的生活品質。
全球關節重建設備市場根據地理位置進一步區隔,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,亞太地區預計將在預測期內實現成長。推動區域市場成長的幾個因素包括對關節重建設備的需求不斷成長、老年人口的增加、關節重建手術數量的增加以及醫療保健支出的增加。
由於該地區聯合手術數量的增加推動了該地區市場的成長,預計北美將在聯合重建器械市場中佔據顯著佔有率。 2023 年美國關節置換登記處(AJRR) 統計了2012 年至2022 年間進行的初次和翻修髖關節和膝關節置換手術超過310 萬例。與2021 年之前的報告相比,手術病例數成長了23.0% 。此外,門診手術中心(ASC) )在美國提供全關節置換術護理方面繼續發揮著越來越重要的作用。目前,ASC 報告了 42,228 例手術病例,自 2022 年以來增加了 84.0%。此外,由於老年人口接受這些手術的比例很高,這些手術數量顯著增加。因此,大量的關節置換手術正在加速該地區該市場的成長。 2022年4月,加拿大統計局發表文章《2021年人口普查顯示加拿大85歲以上人口成長概況》,全國65歲以上人口有730萬人。未來 25 年(到 2046 年),85 歲及以上的人口可能會增加兩倍,達到近 250 萬人。因此,老年人口的增加與關節重建手術的增加有關,從而推動了該地區研究的市場。
服務全球關節重建設備市場的主要公司包括 CONMED Corp.、Johnson & Johnson Services, Inc.、(DePuy Synthes, Inc.)、Medtronic plc、Stryker Corp. 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2022 年 9 月,全球醫療技術公司 Smith+Nephew plc 在日本推出了用於初次和翻修髖關節置換術的 OR3O 雙活動系統。與傳統解決方案相比,雙活動植入物具有小直徑股骨頭,可鎖定到較大的聚乙烯插入物中,從而提高穩定性、降低脫位風險並改善運動範圍。
Global Joint Reconstruction Devices Market Size, Share & Trends Analysis Report by Technique (Joint Replacement, Osteotomy, Arthroscopy, Resurfacing and Arthrodesis), and by Joint Type (Knee, Hip, Shoulder, Ankle, and Others), Forecast Period (2023-2030)
The global joint reconstruction devices market is anticipated to grow at a CAGR of 4.3% during the forecast period (2023-2030). Significant factors attributed to market growth including growing aging population, increasing prevalence of osteoarthritis, minimally invasive techniques, and an increasing number of large joint reconstruction surgeries. With the growing prevalence of orthopedic diseases such as arthritis, osteoporosis, knee injuries, among others, consequential in damage to bones and serious cases, joint reconstruction surgery is the eventual treatment available. In December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 470,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28.0% of all work-induced ill health.
The global joint reconstruction devices market is segmented based on technique, and joint type. Based on the technology, the market is sub-segmented into joint replacement, osteotomy, arthroscopy, resurfacing and arthrodesis. Further, based on joint type, the market is sub-segmented into knee, hip, shoulder, ankle, and others. Where, others include pivot joint, saddle joint. Among the technology, the osteotomy sub-segment is anticipated to hold a considerable share of the market, owing to the improve function, decreasing pain, slow deterioration.
Among the joint, knee sub-segments expected to grow over the forecast period. The segment is driven by the increasing prevalence of osteoporosis and, arthritis globally. According to the National Institutes of Health, in the US, the prevalence of osteoporosis is high, with 12.6% of the population over 50 years of age affected. Furthermore, fractures afflict 1.5 million people annually, which driving up demand for knee replacement products. The advancement of minimally invasive surgical techniques for replacement therapies necessary for the treatment of osteoporosis and arthritis is projected to drive up demand for products. Moreover, knee osteoarthritis is widely prevalent among the older population. Knee joint reconstruction is an effective therapy that aids to decrease pain and improve the function and lifestyle of patients of all ages, especially the elderly population. The number and proportion of people aged 60 years and older in the population is increasing. According to the World Health Organization, in 2019, the number of people aged 60 years and older was 1 billion. This number will increase to 1.4 billion by 2030 and 2.1 billion by 2050. This increase is occurring at an unprecedented pace and will accelerate in coming decades, particularly in developing countries. The expanding older population base in many nations needs joint replacement and reconstructive surgery to improve their quality of life.
The global joint reconstruction devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to grow over the forecast period. Several factors propelling the regional market growth includes the growing demand for joint reconstruction devices, increasing geriatric population, growing number of joint reconstruction surgeries, and rising healthcare expenditure.
North America is expected to hold a prominent share in the joint reconstruction devices market, owing to the increasing number of joint surgeries in the region is propelling the regional market growth. The American Joint Replacement Registry (AJRR) 2023 accounted over 3.1 million primary and revision hip and knee arthroplasty procedures performed between 2012 and 2022. This is a 23.0% growth in procedural cases from the prior report 2021. In addition, Ambulatory surgery centers (ASCs) continue to play an increasingly important role in the delivery of total joint arthroplasty care in the US. There are now 42,228 procedural cases reported by ASCs, an 84.0% increase since 2022. Furthermore, a significant increase in these surgeries, owing to the high percentage of the geriatric population experiences these surgical procedures. Therefore, a high number of joint replacement surgical procedures is accelerating the growth of this market in the region. In April 2022, Statistics Canada published the article "A portrait of Canada's growing population aged 85 and older from the 2021 Census", that there were 7.3 million people aged 65 and older in the country. Over the next 25 years (by 2046), the population aged 85 and older could triple to almost 2.5 million people. Thus, an increasing geriatric population is associated with an increase in joint reconstruction surgery, thus boosting the market studied in the region.
The major companies serving the global joint reconstruction devices market include CONMED Corp., Johnson & Johnson Services, Inc., (DePuy Synthes, Inc.), Medtronic plc, Stryker Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Smith+Nephew plc, the global medical technology business, launched the OR3O Dual Mobility System for use in primary and revision hip arthroplasty in Japan. Compared with traditional solutions, dual mobility implants have a small diameter femoral head that locks into a larger polyethylene insert increasing stability, reducing dislocation risk, and offering improved range of motion.